| 发明名称 | Wnt1 for treatment of cardiovascular disorders and injuries | ||
| 摘要 | The present invention relates to the discovery of the role of Wnt1 in multiple cardiovascular processes, including cardiac repair, angiogenesis, and stimulation of endothelial progenitor cells. This discovery provides methods of using Wnt1 to treat cardiovascular disorders and injuries. | ||
| 申请公布号 | US9186388(B2) | 申请公布日期 | 2015.11.17 |
| 申请号 | US201113885943 | 申请日期 | 2011.11.17 |
| 申请人 | The University of North Carolina at Chapel Hill | 发明人 | Deb Arjun |
| 分类号 | A01N63/00;A61K38/00;A61K48/00;C12N5/02;A61K38/16;A61K31/7088;A61K35/36;A61K35/44;C12N5/00 | 主分类号 | A01N63/00 |
| 代理机构 | Riverside Law LLP | 代理人 | Riverside Law LLP |
| 主权项 | 1. A method of activating the epicardium in the ischemic heart of a subject, comprising delivering recombinant Wnt1 to the subject. | ||
| 地址 | Chapel Hill NC US | ||